| 07:00 |
|
RNS |
RNS Number : 0829X Immunodiagnostic Systems Hldgs PLC 09 February 2012 Immunodiagnostic Systems Holdings plc 9 February 2012 For Immediate Release Appointment of Peel Hunt LLP as Nominated Adviser & Broker 9 February 2012 - Immunodiagnostic Systems Holdings plc ('IDS' or 'the Company') is pleased to announce the appointment, with immediate effect, of Peel Hunt LLP as Nominated Adviser and Broker to the Company. For further information please contact: Immunodiagnostic Systems Holdings plc | Tel: +44 (0) 191 519 0660 | Ian Cookson, Chief Executive Officer |
| Paul Hailes, Finance Director |
|
|
| Peel Hunt LLP | Tel: +44 (0) 20 7418 8900 | James Steel |
| Dr Vijay Barathan |
|
|
| FTI Consulting | Tel: +44 (0) 20 7831 3113 | Ben Atwell |
| Simon Conway |
| Mo Noonan |
|
This information is provided by RNS
The company news service from the London Stock Exchange END APPDMGGZNRLGZZM
More
|
| 02-02-12 |
|
RNS |
RNS Number : 6446W Immunodiagnostic Systems Hldgs PLC 02 February 2012 Immunodiagnostic Systems Holdings plc Director/PDMR Shareholding Immunodiagnostic Systems Holdings plc (the "Company"), a leading producer of diagnostic testing kits and automated systems for the clinical and research markets, announces that it was informed yesterday that Ian Cookson,Chief Executive Officer, bought a total of 2,500 ordinary shares of 2p in the Company on 1 February 2012 at a purchase price of 391.07 pence. Following this transaction Ian Cookson has a beneficial interest in 14,038 shares in the Company. For further information: Immunodiagnostic Systems Holdings plc | Tel: 0191 519 0660 | Ian Cookson, Chief Executive Officer Paul Hailes, Finance Director |
|
|
| N+1 Brewin (Nominated Adviser & Broker) | Tel: 0845 213 3155 | Aubrey Powell Luke Boyce |
|
|
| Walbrook PR Ltd | Tel: 020 7933 8780 | Paul McManus | Mob: 07980 541 893 or paul.mcmanus@walbrookpr.com | Fiona Henson | Mob: 07886 335 992 or fiona.henson@walbrookpr.com |
This information is provided by RNS
The company news service from the London Stock Exchange END RDSBRGDDLXGBGDB
More
|
| 01-02-12 |
|
RNS |
RNS Number : 6216W Immunodiagnostic Systems Hldgs PLC 01 February 2012 Immunodiagnostic Systems Holdings plc Appointment of Nominated Adviser and Broker Immunodiagnostic Systems Holdings plc (the "Company") announces that, as a result of the completion of the transfer of the business of the Corporate Advisory & Broking division of Brewin Dolphin Limited to Nplus1 Brewin LLP ("N+1 Brewin"), with effect from today, N+1 Brewin has been appointed as the Company's Nominated Adviser and Broker. For further information, please contact: Immunodiagnostic Systems Holdings plc Ian Cookson, Chief Executive Officer Paul Hailes, Finance Director | Tel: 0191 519 0660 | N+1 Brewin (Nominated Adviser & Broker) Aubrey Powell/ Luke Boyce | Tel: 020 3201 3710 | Walbrook PR Ltd Paul McManus Fiona Henson | Tel: 020 7933 8780 Mob: 07980 541 893 or paul.mcmanus@walbrookpr.com Mob: 07886 335 992 or fiona.henson@walbrookpr.com |
END
This information is provided by RNS
The company news service from the London Stock Exchange END APPMMGGZKMKGZZM
More
|
| 30-01-12 |
|
RNS |
RNS Number : 3703W Immunodiagnostic Systems Hldgs PLC 30 January 2012 The following replaces the announcement that was released today at 7.00am, RNS 3513W. The announcement now shows the correct the relationship between Dr Wittek and the two Forum entities and correctly states the name of Leonard Wittek. The full amended text appears below. Immunodiagnostic Systems Holdings plc ("IDS" or the "Company") Director/PDMR Shareholding Immunodiagnostic Systems Holdings plc (AIM: IDH), a leading producer of diagnostic testing kits and automated systems for the clinical and research markets, announces that it was informed on 27 January, 2012 of a number of share purchases made by persons connected to Dr. Burkhard Wittek, Non-Executive Director of IDS, on 26 January, 2012. Dr. Wittek is a Director of Forum Venture Capital GmbH ("FVC") and Forum European Smallcaps GmbH ("FES"). Transactions by FVC, FES and other persons connected to Dr. Wittek are summarised below. The percentage holding calculations are based on the Company's issued share capital of 28,403,469 ordinary shares of 2p each ("Ordinary Shares"). The Company does not hold any Ordinary Shares in Treasury. Name | Number of shares bought | Purchase price | Resulting holding | Resulting % |
|
|
|
|
| FVC | 131,824 | 290p | 6,636,188 | 23.36% | FES | 989,876 | 290p | 989,876 | 3.49% | Gabriele Wittek (spouse) | 43,867 | 304.66p | 43,867 | 0.15% | Leonard Wittek (son) | 2,800 | 290p | 2,800 | 0.01% |
|
|
|
|
| Total | 1,168,367 |
| 7,672,731 | 27.01% |
For further information: Immunodiagnostic Systems Holdings plc | Tel: 0191 519 0660 | Ian Cookson, Chief Executive Officer Paul Hailes, Finance Director |
|
|
| Brewin Dolphin Limited | Tel: 020 3201 3710 | Aubrey Powell Luke Boyce |
|
|
| Walbrook PR Ltd | Tel: 020 7933 8780 | Paul McManus | Mob: 07980 541 893 or paul.mcmanus@walbrookpr.com | Fiona Henson | Mob: 07886 335 992 or fiona.henson@walbrookpr.com |
This information is provided by RNS
The company news service from the London Stock Exchange END RDSBMMPTMBTJMFT
More
|
